In the TCGA test group, ERPI involved in chemokine receptors binds chemokines, MHC class II antigen presentation, apoptotic cleavage of cell adhesion proteins, and signaling by FGFR3 fusions in cancer pathways (Figures 5G,H). This evidence concerns the gene FGFR3 and cancer.